<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JIC</journal-id>
<journal-id journal-id-type="hwp">spjic</journal-id>
<journal-id journal-id-type="nlm-ta">J Intensive Care Med</journal-id>
<journal-title>Journal of Intensive Care Medicine</journal-title>
<issn pub-type="ppub">0885-0666</issn>
<issn pub-type="epub">1525-1489</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885066610393626</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885066610393626</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review of a Large Clinical Series</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Influenza A 2009 (H1N1) Virus in Admitted and Critically Ill Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Miller</surname>
<given-names>Andrew C.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393626">1</xref>
<xref ref-type="aff" rid="aff2-0885066610393626">2</xref>
<xref ref-type="aff" rid="aff3-0885066610393626">3</xref>
<xref ref-type="aff" rid="aff4-0885066610393626">4</xref>
<xref ref-type="corresp" rid="corresp1-0885066610393626"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Subramanian</surname>
<given-names>Ramanand A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393626">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Safi</surname>
<given-names>Farnaz</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff5-0885066610393626">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sinert</surname>
<given-names>Richard</given-names>
</name>
<degrees>DO</degrees>
<xref ref-type="aff" rid="aff1-0885066610393626">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zehtabchi</surname>
<given-names>Shahriar</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0885066610393626">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elamin</surname>
<given-names>Elamin M.</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff6-0885066610393626">6</xref>
</contrib>
</contrib-group>
<aff id="aff1-0885066610393626"><label>1</label>Department of Emergency Medicine, State University of New York Downstate Medical Center &amp; Kings County Hospital Center, Brooklyn, NY, USA</aff>
<aff id="aff2-0885066610393626"><label>2</label>Department of Internal Medicine, State University of New York Downstate Medical Center &amp; Kings County Hospital Center, Brooklyn, NY, USA</aff>
<aff id="aff3-0885066610393626"><label>3</label>Department of Pulmonary and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA</aff>
<aff id="aff4-0885066610393626"><label>4</label>Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA</aff>
<aff id="aff5-0885066610393626"><label>5</label>Department of Obstetrics and Gynecology, State University of New York Downstate Medical Center &amp; Kings County Hospital Center, Brooklyn, NY, USA</aff>
<aff id="aff6-0885066610393626"><label>6</label>Department of Pulmonary and Critical Care Medicine, James A. Haley Veterans Hospital and University of South Florida, Tampa, FL, USA</aff>
<author-notes>
<corresp id="corresp1-0885066610393626">Andrew C. Miller, 3459 Fifth Avenue, UPMC Montefiore, NW 628, Pittsburgh, PA. Email: <email>taqwa1@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>1</issue>
<fpage>25</fpage>
<lpage>31</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>11</month>
<year>2009</year>
</date>
<date date-type="received">
<day>26</day>
<month>3</month>
<year>2010</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>4</month>
<year>2010</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Introduction: The influenza A 2009 (H1N1) virus is a pandemic respiratory infection commanding international attention. More information is needed on patient demographics, illness severity, and risk indicators. Methods: A total of 43 patients with H1N1 influenza A 2009 presenting to 2 urban academic medical centers during the first wave were assessed for demographics, triage vital signs, hemograms, and serum chemistries including lactate. Chest X-rays were assessed for infiltrate or effusion. Illness severity markers were recorded including anion gap (AG), strong ion gap (SIG), systemic inflammatory response syndrome score, shock index, confusion, uremia, respiratory rate, blood pressure, and age &gt;= 65 years (CURB-65) score, and pneumonia severity index. Subgroup analysis was performed on asthmatic, pregnant, and intensive care unit (ICU) versus non-ICU patients. Results: Eighty-one percent of patients were women. Pregnancy (34.8%), asthma (39.5%), diabetes mellitus (18.6%), and sickle cell (6.98%) were the most frequent comorbidities. In all, 91% had positive influenza nasopharyngeal direct antigen test, while 9% tested positive only by viral culture or real-time reverse transcriptase polymerase chain reaction (rRT-PCR); 14% required ICU admission; and 20.8% had infiltrate on chest X-ray. A trend toward greater incidence of ICU admission existed among patients with elevated SIG (<italic>P</italic> = .08), however contrary to our prior studies in noninfluenza patients, an elevated SIG in the presence of normal AG and lactate measurements did not correlate with ICU admission. Conclusion: A high percentage of patients with H1N1 presented with underlying comorbid conditions including asthma and pregnancy. Traditional markers of pneumonia severity including CURB-65 score, Pneumonia Severity Index (PSI), serum lactate, and AG did not correlate with ICU admission in patients with H1N1. Strong ion gap effectively identified significant acid−base disturbances not identified by lactate or AG, however the trend of greater ICU admission rates among patients with elevated SIG did not reach statistical significance. Further study is needed to identify clinical tools to aid in risk-stratifying H1N1 patients.</p>
</abstract>
<kwd-group>
<kwd>H1N1</kwd>
<kwd>influenza A</kwd>
<kwd>swine-origin influenza A virus (S-OIV)</kwd>
<kwd>strong ion gap</kwd>
<kwd>pregnancy</kwd>
<kwd>asthma</kwd>
<kwd>critical care</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0885066610393626">
<title>Introduction</title>
<p>The influenza A (H1N1) virus is a pandemic respiratory infection commanding much attention by the international medical community. Published reports have generally focused on epidemiologic factors and patient demographics, however actual H1N1 rates among the general population during the first and second waves remains unknown as many patients were treated in ambulatory care settings or were not seen by a physician. Of greater interest is the characterization of patients requiring admission, and the further description of clinical markers that may aid clinicians in identifying or risk-stratifying H1N1 patients who may require intensive care unit (ICU) admission during subsequent H1N1 waves as well as future seasonal influenza outbreaks. For example, neither the results nor the utility of commonly used assessments of acid–base status, hemodynamic status, nor prognostic scoring systems have been assessed in patients with H1N1.</p>
<p>While the majority of patients with H1N1 will not require hospital admission, it is crucial to develop methods to identify patients with H1N1 being admitted, who have significant acid–base abnormalities and clinical markers that may assist the clinician in determining a proper disposition (ie, medical ward vs critical care setting). Markers of illness severity such as anion gap (AG), serum lactate, pneumonia severity index (PSI), and CURB-65 score are validated and commonly used clinical markers and prognosticators employed in the evaluation of patients with sepsis or pneumonia.<sup><xref ref-type="bibr" rid="bibr1-0885066610393626">1</xref><xref ref-type="bibr" rid="bibr2-0885066610393626"/><xref ref-type="bibr" rid="bibr3-0885066610393626"/><xref ref-type="bibr" rid="bibr4-0885066610393626"/><xref ref-type="bibr" rid="bibr5-0885066610393626"/><xref ref-type="bibr" rid="bibr6-0885066610393626"/><xref ref-type="bibr" rid="bibr7-0885066610393626"/><xref ref-type="bibr" rid="bibr9-0885066610393626"/>–<xref ref-type="bibr" rid="bibr10-0885066610393626">10</xref></sup> More recently, many emergency and critical care practitioners have been using the strong ion gap (SIG) and shock index (SI) to assess acid–base and hemodynamic status in critically ill emergency department (ED) patients,<sup><xref ref-type="bibr" rid="bibr11-0885066610393626">11</xref><xref ref-type="bibr" rid="bibr12-0885066610393626"/><xref ref-type="bibr" rid="bibr13-0885066610393626"/><xref ref-type="bibr" rid="bibr14-0885066610393626"/><xref ref-type="bibr" rid="bibr15-0885066610393626"/>–<xref ref-type="bibr" rid="bibr16-0885066610393626">16</xref></sup> however the utility of such tools in the assessment of patients with H1N1 remains unclear.</p>
<p>In this article, we describe the demographics and symptom characteristics of 43 admitted adult patients who presented during the first wave of Influenza A 2009 (H1N1). We further report the results of the serum SIG, AG, and serum lactate in the assessment of their acid–base status. CURB-65 and PSI scores are also reported. The potential utility of these clinical tools is discussed.</p>
</sec>
<sec id="section2-0885066610393626">
<title>Methods</title>
<p>Data were obtained from the electronic medical records of 43 confirmed and presumptive patients with H1N1 admitted to 2 urban academic medical centers from May 18 to June 24, 2009. The protocol was approved by the Institutional Review Boards at the State University of New York Downstate Medical Center and Kings County Hospital Center. Patient identification remained anonymous, and informed consent was waived due to the observational nature of the study.</p>
<p>In accordance with the Centers for Disease Control and Prevention (CDC) definition, a confirmed H1N1 case was defined as an acute respiratory illness with laboratory-confirmed influenza A 2009 (H1N1) viral infection by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) or viral culture. A probable case was defined as a person with an acute febrile respiratory illness who was positive for influenza A but negative for H1 and H3 by influenza rRT-PCR. Probable H1N1 cases were included, as approximately 96% of non-subtypable specimens during this first wave were later confirmed as pandemic H1N1 virus.<sup><xref ref-type="bibr" rid="bibr17-0885066610393626">17</xref></sup>
</p>
<p>Per hospital policy and the New York City Department of Health and Mental Hygiene (NYCDOHMH) recommendations, only patients presenting with an influenza-like illness (ILI) who were being admitted to the hospital or were critically ill were tested for influenza.<sup><xref ref-type="bibr" rid="bibr18-0885066610393626">18</xref></sup> Inclusion criteria for this study were (<italic>a</italic>) age 18 years or older; (<italic>b</italic>) ILI requiring hospital admission; (<italic>c</italic>) microbiologic confirmation of influenza A by direct antigen analysis (BD Directigen Flu A test kit; Becton, Dickenson and Company, Franklin Lakes, New Jersey.) or viral culture, with confirmation of H1N1 by rRT-PCR when available. Patients were excluded for (<italic>a</italic>) influenza test refusal; and (<italic>b</italic>) ILI not requiring admission.</p>
<p>All tests and imaging procedures were ordered prior to admission by attending physicians or by resident physicians under the supervision of an attending or chief resident. Admission requirements were determined by the ED attending. Specialty consults (eg, critical care, obstetrics, etc) were obtained in the ED when appropriate. Intensive care unit admission criteria and treatment decisions were not standardized and were determined by the ICU attending physician. Nasopharyngeal-swab specimens were collected at admission and respiratory secretions were obtained for intubated patients. Direct antigen testing and viral cultures were performed in-house, whereas rRT-PCR was perfomed by either the CDC or the NYCDOHMH.<sup><xref ref-type="bibr" rid="bibr19-0885066610393626">19</xref></sup> A “confirmed case” was defined as an acute respiratory illness with laboratory-confirmed H1N1 by rRT-PCR or viral culture. Infection control measures including respiratory isolation of infected patients, use of personal protective equipment for health care workers, and strict hand hygiene were strictly enforced. All patients received oseltamivir 75 mg per oral or via enteral feeding tube twice daily for 5 days, beginning the day of admission. No patients received amantadine or rimantadine. Patients also received supportive therapy with oxygen, intravenous hydration, antipyretics, and analgesics when appropriate. Corticosteroids and bronchodilators were administered as indicated on a case-by-case basis. Antibiotics were not routinely administered except when indicated for comorbid conditions. Comorbid conditions were treated as indicated.</p>
<p>Demographic data were recorded including age, gender, length of hospital stay, known influenza contacts, and comorbidities including pregnancy, asthma, diabetes, renal disease, sickle cell, or HIV. Also recorded were each patients presenting symptoms and initial triage vital signs including blood pressure, heart rate, oxygen saturation, temperature, and weight. Laboratory assessment included complete blood count (CBC) with differential, serum electrolyte panel including albumin, magnesium, phosphorus, ionized calcium, serum glucose, as well as pH and PaCO<sub>2</sub>. Per hospital policy, all blood cultures were drawn from de novo venipuncture. No blood cultures were drawn from intravenous or intra-arterial catheters. Chest radiographs were interpreted for presence of infiltrate or effusion.</p>
<p>To objectively assess illness severity, commonly used clinical markers including SI, systemic inflammatory response syndrome (SIRS) score, serum lactate, AG, and CURB-65 score were recorded for each patient.</p>
<p>The SIG was calculated and compared to other markers for correlation with clinical illness severity. The APACHE II and Sequential Organ Failure Assessment (SOFA) scoring systems were not evaluated as not all criteria (specifically the Glasgow Coma Scale) were routinely recorded upon initial presentation.</p>
<p>The SI was calculated according to the equation:
<disp-formula id="disp-formula1-0885066610393626">
<mml:math id="mml-disp1-0885066610393626">
<mml:mrow>
<mml:mtext>SI =</mml:mtext><mml:mfrac>
<mml:mrow>
<mml:mtext>heart rate (HR)</mml:mtext>
</mml:mrow>
<mml:mrow>
<mml:mtext>systolic blood pressure (SBP [normal ≤0.5])</mml:mtext>
</mml:mrow>
</mml:mfrac>

</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-0885066610393626" xlink:href="10.1177_0885066610393626-eq1.tif"/>
</disp-formula></p>
<p>Anion gap (AG) was calculated according to the equation:
<disp-formula id="disp-formula2-0885066610393626">
<mml:math id="mml-disp2-0885066610393626">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mtext>AG + Na</mml:mtext>
</mml:mrow>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msup>
<mml:mrow>
<mml:mtext>/(Cl</mml:mtext>
</mml:mrow>
<mml:mtext>−</mml:mtext>
</mml:msup>
<mml:mtext>C</mml:mtext><mml:msub>
<mml:mtext>O</mml:mtext>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msup>
<mml:mtext> </mml:mtext>
<mml:mo>−</mml:mo>
</mml:msup>
<mml:mtext>)</mml:mtext>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-0885066610393626" xlink:href="10.1177_0885066610393626-eq2.tif"/>
</disp-formula>
</p>
<p>The CURB-65 score was calculated according to the criteria published by Lim et al.<sup><xref ref-type="bibr" rid="bibr2-0885066610393626">2</xref></sup> A recent study reported a significant correlation between the CURB-65 score and the need for hospital admission, requirements for mechanical ventilation, and risk of 30-day mortality.<sup><xref ref-type="bibr" rid="bibr20-0885066610393626">20</xref></sup></p>
<p>The PSI was calculated according to the criteria published by Fine et al.<sup><xref ref-type="bibr" rid="bibr3-0885066610393626">3</xref></sup>
</p>
<p>The SIG was calculated according to the criteria published by Stewart et al.<sup><xref ref-type="bibr" rid="bibr21-0885066610393626">21</xref></sup>
<disp-formula id="disp-formula3-0885066610393626">
<mml:math id="mml-disp3-0885066610393626">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:msub>
<mml:mtext>SIG + Strong Ion Deficit</mml:mtext>
<mml:mrow>
<mml:mtext>apparent</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:msub>
<mml:mtext> (SIDA) − Strong Ion Deficit</mml:mtext>
<mml:mrow>
<mml:mtext>effective</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mtext> (SIDE)</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:msup>
<mml:mtext>SIDA + [(Na</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msup>
<mml:mtext> + K</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msub>
<mml:mtext> − </mml:mtext>
<mml:mtext>i</mml:mtext>
</mml:msub>
<mml:msup>
<mml:mtext>Ca</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msub>
<mml:mtext> + </mml:mtext>
<mml:mtext>i</mml:mtext>
</mml:msub>
<mml:msup>
<mml:mtext>Mg</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msup>
<mml:mtext>) − (Cl</mml:mtext>
<mml:mtext>−</mml:mtext>
</mml:msup>
<mml:mtext> + lactate)]</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:msub>
<mml:mtext>where </mml:mtext>
<mml:mtext>i</mml:mtext>
</mml:msub>
<mml:msup>
<mml:mtext>Mg</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:msup>
<mml:mtext> + Mg</mml:mtext>
<mml:mtext>+</mml:mtext>
</mml:msup>
<mml:mo>×</mml:mo><mml:mtext>0</mml:mtext><mml:mtext>.8333</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mtext>SIDE + [1000</mml:mtext><mml:mo>×</mml:mo><mml:mtext>2</mml:mtext><mml:mtext>.46</mml:mtext><mml:mo>×</mml:mo><mml:msup>
<mml:mtext>10</mml:mtext>
<mml:mrow>
<mml:mtext>−11</mml:mtext>
</mml:mrow>
</mml:msup>
<mml:mo>×</mml:mo><mml:msub>
<mml:mtext>PaCO</mml:mtext>
<mml:mtext>2</mml:mtext>
</mml:msub>
<mml:msup>
<mml:mtext>]/[(10</mml:mtext>
<mml:mrow>
<mml:mtext>−pH</mml:mtext>
</mml:mrow>
</mml:msup>
<mml:msup>
<mml:mtext>) + Alb</mml:mtext>
<mml:mtext>−</mml:mtext>
</mml:msup>
<mml:msup>
<mml:mtext> + Pi</mml:mtext>
<mml:mtext>−</mml:mtext>
</mml:msup>
<mml:mtext>]</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:msup>
<mml:mtext>where, Alb</mml:mtext>
<mml:mtext>−</mml:mtext>
</mml:msup>
<mml:mtext>+10</mml:mtext><mml:mo>×</mml:mo><mml:mtext>Albumin [(0</mml:mtext><mml:mtext>.123   pH) − 0</mml:mtext><mml:mtext>.631]</mml:mtext>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:msup>
<mml:mtext>and, + Pi</mml:mtext>
<mml:mtext>−</mml:mtext></mml:msup>
<mml:mtext>+ (Phos</mml:mtext><mml:mo>×</mml:mo><mml:mtext>0</mml:mtext><mml:mtext>.315)</mml:mtext><mml:mo>×</mml:mo><mml:mtext>[(0</mml:mtext><mml:mtext>.309</mml:mtext><mml:mo>×</mml:mo><mml:mtext>pH) − 0.469]</mml:mtext>
</mml:mtd>
</mml:mtr>
</mml:mtable>

</mml:math>
<graphic alternate-form-of="disp-formula3-0885066610393626" xlink:href="10.1177_0885066610393626-eq3.tif"/>
</disp-formula>
</p>
<sec id="section3-0885066610393626">
<title>Statistics</title>
<p>Data analysis was conducted using SPSS 15.0 software (SPSS Inc, Chicago, Illinois). Means and standard deviation were reported for normally distributed continuous variables. Counts and percentages were reported for nominal data. Group comparisons were analyzed by Student <italic>t</italic> test for continuous variables or Fisher exact test for categorical variables. All tests were 2-tailed. Statistical significance was defined as <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section4-0885066610393626">
<title>Results</title>
<sec id="section5-0885066610393626">
<title>Patient Demographics and Clinical Features</title>
<p>A total of 43 patients were enrolled in the analysis. Patient demographics are detailed in <xref ref-type="table" rid="table1-0885066610393626">Table 1</xref>
. The mean age was 36.4 years (range 19-64), and 81% were women. The mean hospital length-of-stay was 3.7 ± 3.2 days, and 6 (14%) patients required ICU admission. Thirty-two (74%) patients were African American, 6 (14%) Hispanic, 3 (7%) Caucasian, and 2 (5%) South Asian. Three patients were health care workers: 1 nursing student, 1 home attendant, and 1 nonclinical hospital employee. One health care worker presented with both H1N1 and active tuberculosis. The most common comorbidities were asthma and pregnancy, with 5 patients reporting both. No patients reported recent travel, however 1 patient was an airport employee. A total of 39 (90.7%) patients tested positive for influenza A via direct antigen test (DAT) either on initial or repeat testing, but 4 (9.3%) were identified only by viral culture or rRT-PCR testing following negative DAT. This included 1 patient who underwent emergent cesarean section for fetal distress and was admitted to the ICU.</p>
<table-wrap id="table1-0885066610393626" position="float">
<label>Table 1.</label>
<caption>
<p>Patient Demographics</p>
</caption>
<graphic alternate-form-of="table1-0885066610393626" xlink:href="10.1177_0885066610393626-table1.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>All (n = 43)</th>
<th>Pregnant (n = 15)</th>
<th>Asthma (n = 17)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mean age (years)</td>
<td>36.4</td>
<td>27.8</td>
<td>32.3</td>
</tr>
<tr>
<td>Female gender, n (%)</td>
<td>35 (81.4)</td>
<td align="center">–</td>
<td>15 (88.2)</td>
</tr>
<tr>
<td>Pregnant, n (%)</td>
<td>15 (34.8)</td>
<td align="center">–</td>
<td>5 (29.4)</td>
</tr>
<tr>
<td>Asthma, n (%)</td>
<td>17 (39.5)</td>
<td>5 (33.3)</td>
<td align="center">–</td>
</tr>
<tr>
<td>Diabetes, n (%)</td>
<td>8 (18.6)</td>
<td>1 (6.7)</td>
<td>2 (11.8)</td>
</tr>
<tr>
<td>Renal insufficiency, n (%)</td>
<td>2 (4.7)</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>HIV positive, n (%)</td>
<td>3 (7)</td>
<td>1 (6.7)</td>
<td>2 (11.8)</td>
</tr>
<tr>
<td>Sickle cell, n (%)</td>
<td>3 (7)</td>
<td>2 (13.3)</td>
<td>0</td>
</tr>
<tr>
<td>Influenza DAT positive, n (%)</td>
<td>39 (90.7)</td>
<td>11 (73.3)</td>
<td>11 (94.1)</td>
</tr>
<tr>
<td>Influenza DAT negative but culture or PCR positive, n (%)</td>
<td>4 (9.3)</td>
<td>4 (26.7)</td>
<td>1 (5.9)</td>
</tr>
<tr>
<td>Admitted to ICU (%)</td>
<td>6 (14)</td>
<td>2 (13.3)</td>
<td>2 (12.5)</td>
</tr>
<tr>
<td>Weight (kg)<sup><xref ref-type="table-fn" rid="table-fn2-0885066610393626">a</xref></sup></td>
<td>86.7</td>
<td align="center">–</td>
<td>90.6</td>
</tr>
<tr>
<td>BMI<sup><xref ref-type="table-fn" rid="table-fn2-0885066610393626">a</xref></sup></td>
<td>29.73</td>
<td align="center">–</td>
<td>34.95</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0885066610393626">
<p>Abbreviations: BMI, body mass index; DAT, direct antigen test; HIV, human immunodeficiency virus; ICU, intensive care unit; PCR, polymerase chain reaction.</p>
</fn>
<fn id="table-fn2-0885066610393626">
<p><sup>a</sup> Weight and BMI not reported or analyzed in pregnant patients.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A wide range of symptoms were reported by patients upon initial presentation (<xref ref-type="fig" rid="fig1-0885066610393626">Figure 1</xref>). Whereas 73% of patients reported cough and 25% reported sputum production, pregnant patients more commonly reported abdominal and gastrointestinal complaints including nausea (16%), vomiting (11%), abdominal pain (7%), or diarrhea (5%). In all, 24 patients had admission chest radiographs. Of those patients, 5 (20.8%) had identifiable infiltrates on chest X-ray. Pregnant patients not requiring ICU admission did not routinely have chest X-rays.</p>
<fig id="fig1-0885066610393626" position="float">
<label>Figure 1.</label>
<caption>
<p>Clinical features of patients with H1N1 Influenza A at presentation.</p>
</caption>
<graphic alternate-form-of="fig1-0885066610393626" xlink:href="10.1177_0885066610393626-fig1.tif"/>
</fig>
<p>Six (14%) patients were admitted to the ICU. Univariate analysis revealed no significant differences in patient demographics between those admitted to the ICU versus the general medicine wards (<xref ref-type="table" rid="table2-0885066610393626">Table 2</xref>).</p>
<table-wrap id="table2-0885066610393626" position="float">
<label>Table 2.</label>
<caption>
<p>Univariate Analysis of Clinical and Laboratory Variables Associated With the Combined Outcome of ICU Care or Death<sup><xref ref-type="table-fn" rid="table-fn4-0885066610393626">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-0885066610393626" xlink:href="10.1177_0885066610393626-table2.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>No ICU Care (n = 37)</th>
<th>ICU Care (n = 6)</th>
<th>
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (year)</td>
<td>36.08 ± 14.4</td>
<td>38.5 ± 14.9</td>
<td>.71</td>
</tr>
<tr>
<td>Female gender (%)<sup><xref ref-type="table-fn" rid="table-fn5-0885066610393626">b</xref></sup></td>
<td>31 (72.1; 83.8)</td>
<td>4 (9.3; 66.7)</td>
<td>.31</td>
</tr>
<tr>
<td>Pregnant<sup><xref ref-type="table-fn" rid="table-fn5-0885066610393626">b</xref></sup></td>
<td>13 (30.2; 35.1)</td>
<td>2 (4.7; 33.3)</td>
<td>.66</td>
</tr>
<tr>
<td>Asthma (%)<sup><xref ref-type="table-fn" rid="table-fn5-0885066610393626">b</xref></sup></td>
<td>15 (34.9; 40.5)</td>
<td>2 (4.7; 33.3)</td>
<td>.55</td>
</tr>
<tr>
<td>Hemoglobin (g/dL)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>12.2 ± 1.3</td>
<td>12.2 ± 2.3</td>
<td>.94</td>
</tr>
<tr>
<td>WBC (×10<sup>−9</sup>/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>8.2 ± 2.7</td>
<td>10.7 ± 5.2</td>
<td>.08</td>
</tr>
<tr>
<td>Neutrophils (×10<sup>−9</sup>/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>6.5 ± 2.5</td>
<td>8.0 ± 3.5</td>
<td>.20</td>
</tr>
<tr>
<td>Lymphocytes (×10<sup>−9</sup>/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>1.04 ± 1.04</td>
<td>1.8 ± 1.8</td>
<td>.15</td>
</tr>
<tr>
<td>Platelets (×10<sup>−9</sup>/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>244 ± 58</td>
<td>274 ±131</td>
<td>.36</td>
</tr>
<tr>
<td>Sodium (mmol/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>135.2 ± 3</td>
<td>133.5 ± 2.7</td>
<td>.21</td>
</tr>
<tr>
<td>Urea (mmol/L)<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>14.9 ± 15.9</td>
<td>10.7 ± 4.1</td>
<td>.52</td>
</tr>
<tr>
<td>Lactate<sup><xref ref-type="table-fn" rid="table-fn6-0885066610393626">c</xref></sup></td>
<td>1.6 ± 0.7</td>
<td>1.1 ± 0.7</td>
<td>.20</td>
</tr>
<tr>
<td>Blood cultures positive (n/total n)<sup><xref ref-type="table-fn" rid="table-fn7-0885066610393626">d</xref></sup></td>
<td>1/22</td>
<td>2/4</td>
<td>.023</td>
</tr>
<tr>
<td>Number of positive blood cultures that were contaminants requiring repeat (n/total n)<sup><xref ref-type="table-fn" rid="table-fn7-0885066610393626">d</xref></sup></td>
<td>1/1</td>
<td>2/2</td>
<td>.052</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0885066610393626">
<p>Abbreviations: ICU, intensive care unit; WBC, white blood cell.</p>
</fn>
<fn id="table-fn4-0885066610393626">
<p><sup>a</sup> No significant differences were observed between ICU and non-ICU patients. All patients had each of the above parameters assessed with exception of blood cultures.</p>
</fn>
<fn id="table-fn5-0885066610393626">
<p>
<sup>b</sup> Expressed as n (% all patients; % subgroup).</p>
</fn>
<fn id="table-fn6-0885066610393626">
<p>
<sup>c</sup> Expressed as mean ± standard deviation.</p>
</fn>
<fn id="table-fn7-0885066610393626">
<p>
<sup>d</sup> In all, 26 patients had blood cultures drawn: 22 non-ICU and 4 ICU.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-0885066610393626">
<title>Hematologic and Serum Chemistry Parameters</title>
<p>Hematologic and chemistry parameters are reported in <xref ref-type="table" rid="table2-0885066610393626">Table 2</xref> as mean ± standard deviation. The mean leukocyte (white blood cell [WBC]) counts were not significantly elevated, however, elevated serum neutrophil percentages were noted. There are no statistically significant trend toward higher WBC counts among ICU versus non-ICU patients (<italic>P</italic> = .08). No significant differences were observed between ICU versus non-ICU patients in neutrophil, platelet, or lymphocyte counts. Mean serum chemistry, electrolyte, and lactate measurements were normal. Serum sodium, urea, and lactate levels did not differ significantly between ICU and non-ICU populations. Among patients who had blood cultures drawn, ICU patients (2 of 4) were significantly more likely to have positive blood cultures than medically ward patients (1 of 22; <italic>P</italic> = .023), however these were universally single-bottle contaminants. One gravid patient that suffered spontaneous abortion had a single bottle contaminated blood culture (corynebacterium) that was negative on repeat testing. This patient received no antibiotics other than the antiviral oseltamivir.</p>
</sec>
<sec id="section7-0885066610393626">
<title>Illness Severity and Scoring Systems</title>
<p>The full analysis of illness severity markers and scoring systems is listed in <xref ref-type="table" rid="table3-0885066610393626">Table 3</xref>. The mean SIRS score was 2.19 ± 0.994, being slightly higher in pregnant and asthmatic patients (<xref ref-type="table" rid="table4-0885066610393626">Table 4</xref>). Similarly, the mean SI was 0.88 ± 0.23 (reference ≤ 0.5). Mean serum lactate and AG levels were within normal reference ranges, however, as shown in <xref ref-type="table" rid="table3-0885066610393626">Table 3</xref>, the mean SIG was elevated at 5.04 ± 3.43 (reference ≤ 2). Nine patients with normal AG and lactate measurements had an elevated SIG suggesting a significant occult acid–base disturbance. Pneumonia severity index and CURB-65 scores were not associated with increased mortality and did not differ significantly between ICU and non-ICU patients.</p>
<table-wrap id="table3-0885066610393626" position="float">
<label>Table 3.</label>
<caption>
<p>Assessment of Biomarkers and Illness-Severity Scoring Systems</p>
</caption>
<graphic alternate-form-of="table3-0885066610393626" xlink:href="10.1177_0885066610393626-table3.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>All (n)</th>
<th>Pregnant (n)</th>
<th>Asthma (n)</th>
</tr>
</thead>
<tbody>
<tr>
<td>SIRS score (mean ± SD)</td>
<td>2.19 ± 0.994 (43)</td>
<td>2.40 ± 0.91 (15)</td>
<td>2.35 ± 0.996 (17)</td>
</tr>
<tr>
<td>Shock index (mean ± SD)</td>
<td>0.88 ± 0.23 (43)</td>
<td>1.05 ± 0.22 (15)</td>
<td>0.94 ± 0.24 (17)</td>
</tr>
<tr>
<td>Lactate (mean ± SD)</td>
<td>1.52 ± 0.72 (24)</td>
<td>0.6 ± 0.0 (2)</td>
<td>1.45 ± 0.84 (9)</td>
</tr>
<tr>
<td>AG (mean ± SD)</td>
<td>11.12 ± 3.91 (43)</td>
<td>9.7 ± 4.16 (15)</td>
<td>11.3 ± 2.76 (17)</td>
</tr>
<tr>
<td>SIG<sup>a</sup> (mean ± SD)</td>
<td>5.04 ± 3.43 (16)</td>
<td align="center">–</td>
<td>3.9 ± 3.89 (7)</td>
</tr>
<tr>
<td>CURB-65 score (mean ± SD)</td>
<td>1.0 ± 0.76 (43)</td>
<td>0.73 ± 0.7 (15)</td>
<td>1.3 ± 0.69 (17)</td>
</tr>
<tr>
<td>Pneumonia severity index (mean ± SD)</td>
<td>48.11 ± 32.9 (18)</td>
<td>21.5 ± 4.0 (3)</td>
<td>47.88 ± 26.52 (8)</td>
</tr>
<tr>
<td>% Patients with lactate ≤2.2 and AG ≤15, then SIG &gt;2<sup>a</sup></td>
<td>23.3 (10)</td>
<td align="center">–</td>
<td>17.6 (3)</td>
</tr>
<tr>
<td>% Patients with lactate ≤2.2 and AG ≤15, SIG &gt;2, then required ICU admission<sup>a</sup></td>
<td>30 (3)</td>
<td align="center">–</td>
<td>5.9 (1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0885066610393626">
<p>Abbreviations: AG, anion gap; CURB-65, confusion, uremia, respiratory rate, blood pressure, and age &gt;= 65 years; ICU, intensive care unit; SIG, strong ion gap; SIRS, systemic inflammatory response syndrome. Strong ion gap was not calculated for gravid patients. This is because magnesium and phosphorous are not part of the routine admission laboratories by the Department of Obstetrics and Gynecology, thus precluding SIG calculation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table4-0885066610393626" position="float">
<label>Table 4.</label>
<caption>
<p>Biomarkers and Illness Severity Scoring Systems Associated With the Combined Outcome of ICU Care or Death</p>
</caption>
<graphic alternate-form-of="table4-0885066610393626" xlink:href="10.1177_0885066610393626-table4.tif"/>
<table>
<thead>
<tr>
<th>Variable</th>
<th>No ICU Care (n)</th>
<th>ICU Care (n)</th>
<th>
<italic>P</italic> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>SIRS score ± SD</td>
<td>2.14 ± 0.99 (37)</td>
<td>2.50 ± 1.05 (6)</td>
<td>.417</td>
</tr>
<tr>
<td>Shock index ± SD</td>
<td>0.89 ± 0.24 (37)</td>
<td>0.82 ± 0.08 (6)</td>
<td>.497</td>
</tr>
<tr>
<td>% Patients with lactate ≥2.2</td>
<td>8.1 (3)</td>
<td>16.7 (1)</td>
<td>.47</td>
</tr>
<tr>
<td>% Patients with AG ≥15</td>
<td>21.6 (8)</td>
<td>33.3 (2)</td>
<td>.61</td>
</tr>
<tr>
<td>% Patients with SIG<sup><xref ref-type="table-fn" rid="table-fn10-0885066610393626">a</xref></sup> ≥2</td>
<td>27 (10)</td>
<td>66.7 (4)</td>
<td>.08</td>
</tr>
<tr>
<td>CURB-65 score</td>
<td>0.97 ± 0.69 (37)</td>
<td>1.17 ± 1.17 (6)</td>
<td>.57</td>
</tr>
<tr>
<td>Pneumonia severity index</td>
<td>50.5 ± 35.3 (13)</td>
<td>42 ± 28.8 (5)</td>
<td>.64</td>
</tr>
<tr>
<td>% Normal lactate (≤2.2), normal AG (≤15), but elevated SIG (&gt;2)</td>
<td>18.9 (7)</td>
<td>33.3 (2)</td>
<td>.59</td>
</tr>
<tr>
<td>% Patients with SI ≥0.9</td>
<td>37.2 (16)</td>
<td>0</td>
<td>.049</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-0885066610393626">
<p>Abbreviations: AG, anion gap; CURB-65, confusion, uremia, respiratory rate, blood pressure, and age &gt;= 65 years; ICU, intensive care unit; SI, shock index; SIG, strong ion gap.</p>
</fn>
<fn id="table-fn10-0885066610393626">
<p>
<sup>a</sup> Strong ion gap was not measured in pregnant patients. N = 16 for SIG calculations.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>No significant difference existed between ICU versus non-ICU patients for SIRS score, SI, elevated lactate, AG, SIG, CURB-65 score, or PSI. As expected, all patients with elevated AG and lactate levels had an elevated SIG.</p>
</sec>
</sec>
<sec id="section8-0885066610393626">
<title>Discussion</title>
<p>The influenza A 2009 (H1N1) virus is a pandemic respiratory infection commanding much attention by the international medical community. This virus has 2 genes from avian influenza that entered Eurasian swine in 1979, 3 from traditional H1N1 North American swine, and a final gene transmitted from humans that was originally acquired from birds in 1968.<sup><xref ref-type="bibr" rid="bibr22-0885066610393626">22</xref></sup> This novel mixture prompted a global race for disaster preparedness, vaccine development and distribution, therapeutic advancements, and further patient characterization in hopes of developing techniques through which to identify, risk stratify, and treat patients with H1N1.</p>
<p>One obstacle presented by the initial H1N1 pandemic was properly diagnosing and distinguishing patients with H1N1 from patients with ILI of other viral or pneumonic etiologies. This was augmented by the relatively low sensitivity of influenza direct antigen testing and the poor availability of rRT-PCR in many clinical settings. It has been reported that approximately 96% of non-subtypable specimens during this first wave were later confirmed as pandemic H1N1 virus.<sup><xref ref-type="bibr" rid="bibr17-0885066610393626">17</xref></sup> However, it is unclear whether this will be true for subsequent waves, or in future years. To address this issue, Cunha et al (New York) devised a clinical scoring system aimed at aiding the presumptive diagnosis of H1N1 in ILI patients with a negative DAT.<sup><xref ref-type="bibr" rid="bibr23-0885066610393626">23</xref></sup> Although such a detailed system may not be practical for routine administration, such a weighted scoring system may be useful in the proper clinical context.</p>
<p>Once appropriately identified, the next challenge was to develop a means with which to risk stratify patients. Therefore, data from the first wave of patients with H1N1 in 2 New York City hospitals were analyzed in hopes of identifying relevant associations and correlations with illness severity. This information could potentially assist clinicians during subsequent H1N1 waves, as well as future influenza epidemics or pandemics.</p>
<p>The rate of ICU admission in this series was approximately 14%, which is lower than some prior studies.<sup><xref ref-type="bibr" rid="bibr24-0885066610393626">24</xref><xref ref-type="bibr" rid="bibr25-0885066610393626"/>–<xref ref-type="bibr" rid="bibr26-0885066610393626">26</xref></sup> In a study of 399 patients with H1N1 by Dawood et al,<sup><xref ref-type="bibr" rid="bibr24-0885066610393626">24</xref></sup> 36 (9%) patients required admission. However, these investigators only had access to data for 22 of the admitted patients. Of the 22 patients, 8 (36% of admitted) required ICU admission.<sup><xref ref-type="bibr" rid="bibr24-0885066610393626">24</xref></sup> This difference in the ICU admission rate may be a reflection of a different patient population, a potential difference in the influenza strain, or perhaps a higher threshold for ICU admission at our institution.</p>
<p>In our study, patient demographics and most variables did not differ significantly between ICU versus non-ICU patients. Surprisingly, lactate levels and AG measurements also did not differ significantly between ICU and non-ICU patients. Moreover, traditional pneumonia scoring systems such as CURB-65 score and PSI did not correlate significantly with need for ICU admission.</p>
<p>Previously we have found the serum SIG to be a more sensitive marker of illness severity in critically ill medical patients,<sup><xref ref-type="bibr" rid="bibr27-0885066610393626">27</xref>,<xref ref-type="bibr" rid="bibr28-0885066610393626">28</xref></sup> thus we assessed whether SIG correlated with need for ICU admission in patients with H1N1. Strong ion gap has been shown to reveal subtle yet clinically important acid–base abnormalities and correlates with adverse outcomes even when more commonly used illness severity markers such as the traditional or corrected AG calculations, SI, or even lactate are normal.<sup><xref ref-type="bibr" rid="bibr27-0885066610393626">27</xref>–<xref ref-type="bibr" rid="bibr29-0885066610393626">29</xref></sup> It has been shown that SIG better accounts for unmeasured anions because it corrects for alterations in pH, PaCO<sub>2</sub>, other cations (calcium and magnesium), and anions (albumin and phosphorous) not included in the traditional or corrected AG calculations.<sup><xref ref-type="bibr" rid="bibr21-0885066610393626">21</xref></sup> As such, it is the gold standard for identifying unmeasured anions as an important marker for life-threatening metabolic derangements including septic shock, ketosis, and toxins.<sup><xref ref-type="bibr" rid="bibr30-0885066610393626">30</xref></sup> It has previously been demonstrated that patients with severe metabolic disturbances but normal laboratories may be identified using the SIG.<sup><xref ref-type="bibr" rid="bibr29-0885066610393626">29</xref></sup> Similarly, we have found the SIG to be a more sensitive marker of illness severity in critically ill medical patients.<sup><xref ref-type="bibr" rid="bibr27-0885066610393626">27</xref>,<xref ref-type="bibr" rid="bibr28-0885066610393626">28</xref></sup> In this analysis, a trend toward greater incidence of ICU admission existed among patients with elevated SIG (<italic>P</italic> = .08), however contrary to our prior studies in noninfluenza patients, an elevated SIG in the presence of normal AG and lactate measurements did not correlate with ICU admission. It is unclear why the utility of SIG for identifying critically ill patients differed in this study relative to our prior studies. It is possible that the sample size was too small to detect a significant difference. Alternatively, differences in diagnosis/patient populations may have played a role. In the prior analyses, there were very few influenza patients. The current analysis included only patients with H1N1, and as such, assesses a different patient population. Further study is warranted to further characterize which, if any, markers of illness severity will aid in the risk stratification of patients with H1N1.</p>
<sec id="section9-0885066610393626">
<title>Limitations</title>
<p>The results of this study must be interpreted in light of several methodological limitations. This study relied on abstracting data from patient charts. Accordingly, some patients had missing information. Certain data that were reliant on patient memory, such as details concerning exposure history and timing of onset of symptoms, may be affected by their recall bias. Additionally, this study did not include all ILI patients presenting to the ED as this was not the focus of this study. As such, it cannot provide a decision rule to distinguish H1N1 from non-H1N1 illness. Rather, this study provides a profile of patients with H1N1 who were admitted to the hospital. As such, it offers important information on the sensitivity of certain findings but not the specificity. Lastly, due to our small sample size, we were not able to perform a multivariate analysis. A multivariate logistic regression would more accurately identify factors that could predict the outcome while correcting for all other variables.</p>
</sec>
</sec>
<sec id="section10-0885066610393626">
<title>Conclusion</title>
<p>Among the admitted patients with H1N1 in this study, there was a female predominance. A high percentage of patients presented with underlying medical comorbidities including asthma, pregnancy, diabetes, and sickle cell disease. The ED assessment of traditional markers of illness severity including serum lactate, AG, CURB-65 score, and PSI did not correlate with ICU admission rates in patients with H1N1. A trend toward greater incidence of ICU admission existed among patients with elevated SIG, however contrary to our prior studies in noninfluenza patients, an elevated SIG in the presence of normal AG and lactate measurements did not correlate with ICU admission. The study sample size and its descriptive nature limit what conclusions may be drawn, however, the results of this and other descriptive studies are essential to aiding the development of further prospective investigations. Future investigations may allow more accurate assessment of disease severity in patients with H1N1, improve assessment of acid–base status, improve admission to appropriate monitored or critical care settings, or may potentially alter treatment outcomes in patients with Influenza A (H1N1).</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0885066610393626">
<p>The author(s) declared no conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0885066610393626">
<p>The author(s) received no financial support for the research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0885066610393626">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imran</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurup</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>P.</given-names>
</name>
</person-group> <article-title>Early predictors of mortality in pneumococcal bacteraemia</article-title>. <source>Ann Acad Med Singapore</source>. <year>2005</year>;<volume>34</volume>(<issue>7</issue>):<fpage>426</fpage>–<lpage>431</lpage>.</citation>
</ref>
<ref id="bibr2-0885066610393626">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>van der Eerden</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Laing</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study</article-title>. <source>Thorax</source>. <year>2003</year>;<volume>58</volume>(<issue>5</issue>):<fpage>377</fpage>–<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr3-0885066610393626">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Auble</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Yealy</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>A prediction rule to identify low-risk patients with community-acquired pneumonia</article-title>. <source>N Engl J Med</source>. <year>1997</year>;<volume>336</volume>(<issue>4</issue>):<fpage>243</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr4-0885066610393626">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ufberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nathanson</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>NI.</given-names>
</name>
</person-group> <article-title>Anion gap as a screening tool for elevated lactate in patients with an increased risk of developing sepsis in the Emergency Department</article-title>. <source>J Emerg Med</source>. <year>2009</year>;<volume>36</volume>(<issue>4</issue>):<fpage>391</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr5-0885066610393626">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapiro</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Talmor</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum lactate as a predictor of mortality in emergency department patients with infection</article-title>. <source>Ann Emerg Med</source>. <year>2005</year>;<volume>45</volume>(<issue>5</issue>):<fpage>524</fpage>–<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr6-0885066610393626">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valencia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Badia</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cavalcanti</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores</article-title>. <source>Chest</source>. <year>2007</year>;<volume>132</volume>(<issue>2</issue>):<fpage>515</fpage>–<lpage>522</lpage>.</citation>
</ref>
<ref id="bibr7-0885066610393626">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angus</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Marrie</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Obrosky</surname>
<given-names>DS</given-names>
</name>
<etal/>
</person-group>. <article-title>Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2002</year>;<volume>166</volume>(<issue>5</issue>):<fpage>717</fpage>–<lpage>723</lpage>.</citation>
</ref>
<ref id="bibr8-0885066610393626">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howell</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Donnino</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Talmor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Clardy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ngo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>NI.</given-names>
</name>
</person-group> <article-title>Performance of severity of illness scoring systems in emergency department patients with infection</article-title>. <source>Acad Emerg Med</source>. <year>2007</year>;<volume>14</volume>(<issue>8</issue>):<fpage>709</fpage>–<lpage>714</lpage>.</citation>
</ref>
<ref id="bibr9-0885066610393626">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trzeciak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dellinger</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Chansky</surname>
<given-names>ME</given-names>
</name>
<etal/>
</person-group>. <article-title>Serum lactate as a predictor of mortality in patients with infection</article-title>. <source>Intensive Care Med</source>. <year>2007</year>;<volume>33</volume>(<issue>6</issue>):<fpage>970</fpage>–<lpage>977</lpage>.</citation>
</ref>
<ref id="bibr10-0885066610393626">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Rivers</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>BP</given-names>
</name>
<etal/>
</person-group>. <article-title>Early lactate clearance is associated with improved outcome in severe sepsis and septic shock</article-title>. <source>Crit Care Med</source>. <year>2004</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1637</fpage>–<lpage>1642</lpage>.</citation>
</ref>
<ref id="bibr11-0885066610393626">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noritomi</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Soriano</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study</article-title>. <source>Crit Care Med</source>. <year>2009</year>;<volume>37</volume>(<issue>10</issue>):<fpage>2733</fpage>–<lpage>2739</lpage>.</citation>
</ref>
<ref id="bibr12-0885066610393626">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Piva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Paltenghi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Candiani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Latronico</surname>
<given-names>N.</given-names>
</name>
</person-group> <article-title>The early phase of critical illness is a progressive acidic state due to unmeasured anions</article-title>. <source>Eur J Anaesthesiol</source>. <year>2008</year>;<volume>25</volume>(<issue>7</issue>):<fpage>566</fpage>–<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr13-0885066610393626">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Pinsky</surname>
<given-names>MR.</given-names>
</name>
</person-group> <article-title>Strong ion gap: a methodology for exploring unexplained anions</article-title>. <source>J Crit Care</source>. <year>1995</year>;<volume>10</volume>(<issue>2</issue>):<fpage>51</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr14-0885066610393626">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Menises</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Masevicius</surname>
<given-names>FD</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparison of three different methods of evaluation of metabolic acid-base disorders</article-title>. <source>Crit Care Med</source>. <year>2007</year>;<volume>35</volume>(<issue>5</issue>):<fpage>1264</fpage>–<lpage>1270</lpage>.</citation>
</ref>
<ref id="bibr15-0885066610393626">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moviat</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Haren</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van der Hoeven</surname>
<given-names>H.</given-names>
</name>
</person-group> <article-title>Conventional or phsiochemical approach in intensive care unit patients with metabolic acidosis</article-title>. <source>Crit Care</source>. <year>2003</year>;<volume>7</volume>(<issue>3</issue>):<fpage>R41</fpage>–<lpage>R45</lpage>.</citation>
</ref>
<ref id="bibr16-0885066610393626">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasubramanyan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Havens</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>GM.</given-names>
</name>
</person-group> <article-title>Unmeasured anions identified by the Fencl-Stewart method predict mortality better than base excess, anion gap, and lactate in patients in the pediatric intensive care unit</article-title>. <source>Crit Care Med</source>. <year>1999</year>;<volume>27</volume>(<issue>8</issue>):<fpage>1577</fpage>–<lpage>1581</lpage>.</citation>
</ref>
<ref id="bibr17-0885066610393626">
<label>17</label>
<citation citation-type="journal">
<collab collab-type="author">Centers for Disease Control and Prevention (CDC)</collab>. <article-title>Hospitalized patients with novel influenza A (H1N1) virus infection—California, April–May, 2009</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2009</year>;<volume>58</volume>(<issue>19</issue>):<fpage>536</fpage>–<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr18-0885066610393626">
<label>18</label>
<citation citation-type="web">
<collab collab-type="author">State of New York Department of Health</collab>. <article-title>Health Advisory: Clinical Guidance for Healthcare Providers for the 2009-2010 Influenza Season</article-title>. <month>September</month> <day>18</day>, <year>2009</year>. <ext-link ext-link-type="uri" xlink:href="http://www.nyacp.org/files/public/Clinical%20Guidance%20on%20H1N1.pdf">http://www.nyacp.org/files/public/Clinical%20Guidance%20on%20H1N1.pdf</ext-link>. <comment>Accessed October 10, 2009</comment>.</citation>
</ref>
<ref id="bibr19-0885066610393626">
<label>19</label>
<citation citation-type="web">
<collab collab-type="author">World Health Organization</collab>. <article-title>CDC protocol of realtime RTPCR for influenza A(H1N1)</article-title>. <month>April</month> <day>28</day>, <year>2009</year>. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf">http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf</ext-link>. <comment>Accessed on June 15, 2009</comment>.</citation>
</ref>
<ref id="bibr20-0885066610393626">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capelastegui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>España</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Quintana</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>Validation of a predictive rule for the management of community-acquired pneumonia</article-title>. <source>Eur Respir J</source>. <year>2006</year>;<volume>27</volume>(<issue>1</issue>):<fpage>151</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr21-0885066610393626">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Modern quantitative acid-base chemistry</article-title>. <source>Can J Physiol Pharmacol</source>. <year>1983</year>;<volume>61</volume>(<issue>12</issue>):<fpage>1444</fpage>–<lpage>1461</lpage>.</citation>
</ref>
<ref id="bibr22-0885066610393626">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Swine flu outbreak. New details on virus’s promiscuous past</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>(<issue>5931</issue>):<fpage>1127</fpage>.</citation>
</ref>
<ref id="bibr23-0885066610393626">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunha</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Syed</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mickail</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Strollo</surname>
<given-names>S.</given-names>
</name>
</person-group> <article-title>Rapid clinical diagnosis in fatal swine influenza (H1N1) pneumonia in an adult with negative rapid influenza diagnostic tests (RIDTs): diagnostic swine influenza triad</article-title>. <source>Heart Lung</source>. <year>2010</year>;<volume>39</volume>(<issue>1</issue>):<fpage>78</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr24-0885066610393626">
<label>24</label>
<citation citation-type="journal">
<collab collab-type="author">Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team</collab>, <person-group person-group-type="author">
<name>
<surname>Dawood</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Emergence of a novel swine-origin influenza A (H1N1) virus in humans</article-title>. <source>New Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>25</issue>):<fpage>2605</fpage>–<lpage>2615</lpage>.</citation>
</ref>
<ref id="bibr25-0885066610393626">
<label>25</label>
<citation citation-type="journal">
<collab collab-type="author">Centers for Disease Control and Prevention (CDC)</collab>. <article-title>Hospitalized patients with novel A (H1N1) virus infection—California, April-May 2009</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2009</year>;<volume>58</volume>(<issue>19</issue>):<fpage>470</fpage>–<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr26-0885066610393626">
<label>26</label>
<citation citation-type="journal">
<collab collab-type="author">Centers for Disease Control and Prevention (CDC)</collab>. <article-title>Intensive care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2009</year>;<volume>58</volume>(<issue>27</issue>):<fpage>749</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr27-0885066610393626">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinert</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bright</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Paladino</surname>
<given-names>L.</given-names>
</name>
</person-group> <article-title>Strong ion gap compared to anion gap in critically ill patients</article-title>. <source>Acad Emerg Med</source>. <year>2009</year>;<volume>16</volume>(<issue>4</issue>):<fpage>S264</fpage>–<lpage>S265</lpage>.</citation>
</ref>
<ref id="bibr28-0885066610393626">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sinert</surname>
<given-names>R.</given-names>
</name>
</person-group> <article-title>Strong ion gap is better than serum lactate or anion gap at predicting intensive care unit admission, in- hospital mortality, or need for transfusion or vasopressor support</article-title>. <source>Prehosp Disast Med</source>. <year>2009</year>;<volume>24</volume>(<issue>2</issue>):<fpage>s30</fpage>–<lpage>s31</lpage>.</citation>
</ref>
<ref id="bibr29-0885066610393626">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kellum</surname>
<given-names>JA.</given-names>
</name>
</person-group> <article-title>Disorders of acid-base balance</article-title>. <source>Crit Care Med</source>. <year>2007</year>;<volume>35</volume>(<issue>11</issue>):<fpage>2630</fpage>–<lpage>2636</lpage>.</citation>
</ref>
<ref id="bibr30-0885066610393626">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fencl</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Leith</surname>
<given-names>DE.</given-names>
</name>
</person-group> <article-title>Stewart’s quantitative acid-base chemistry: applications in biology and medicine</article-title>. <source>Respir Physiol</source>. <year>1993</year>;<volume>91</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>16</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>